These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2. Nishizawa EE, Williams DJ, Connell CL. Thromb Res; 1983 May 01; 30(3):289-96. PubMed ID: 6868025 [Abstract] [Full Text] [Related]
3. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction. Parise LV, Venton DL, Le Breton GC. J Pharmacol Exp Ther; 1984 Jan 01; 228(1):240-4. PubMed ID: 6319669 [Abstract] [Full Text] [Related]
4. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2. Svensson J. Acta Biol Med Ger; 1978 Jan 01; 37(5-6):731-40. PubMed ID: 742285 [Abstract] [Full Text] [Related]
10. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Quilley J, McGiff JC, Nasjletti A. Br J Pharmacol; 1989 Jan 01; 96(1):111-6. PubMed ID: 2522332 [Abstract] [Full Text] [Related]
11. Antiaggregatory effects of thromboxane receptor antagonists in vivo. Darius H, Lefer AM. Thromb Res; 1985 Dec 01; 40(5):663-75. PubMed ID: 2935972 [Abstract] [Full Text] [Related]
12. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Lefer AM, Smith EF, Araki H, Smith JB, Aharony D, Claremon DA, Magolda RL, Nicolaou KC. Proc Natl Acad Sci U S A; 1980 Mar 01; 77(3):1706-10. PubMed ID: 6929517 [Abstract] [Full Text] [Related]